Evaluation of Comparative efficacy of Amalkyadi Kaphghna basti versus Lekhana basti in the management of Dyslipedemia Medoroga A Randomized Controlled Clinical Trial

Mahatma Gandhi Ayurved College Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients who are willing to give Written Informed Cosent
•Clinical cases of Dyslipidemia as per 1CD 10 Criteria E78 point 5 diagnosed with either sex between the age group of 20 to 50 years
•Diagnosed and confirmed cases of Dyslipidemia according to National Cholesterol Education Program and Adult Treatment Panel 3
•NCEP ATPIII 2001 as follows
•Total cholesterol less than or equal to 200 mg per dL and or
•LDL from 130 to 189 mg per dL and or
•Sr Triglycerides between 150 to 499 mg per dL and or
•Sr HDL more than 40mg per dL

•Patients who are not willing to give Written Informed Consent
•Patients with Unstable Angina myocardial infarction stroke transient ischemic attack cardiovascular surgery or major operations within 6 months prior to screening visit
•Patient having systemic illness like Tuberculosis Carcinoma Endocrine disorders and Renal or Liver disorder
•Drug induced Dyslipidemia like steroids etcPregnant Lactating women
•Patients with Ano-rectal disorders like Fissure Fistula Haemorrhoids etc
•Patients with Hypothyroidism
•Patients with NIDDM
•Patients with Hypertension

发起方